ATE169294T1 - Verbindungen zur behandlung von bauchentzündungen - Google Patents

Verbindungen zur behandlung von bauchentzündungen

Info

Publication number
ATE169294T1
ATE169294T1 AT90313923T AT90313923T ATE169294T1 AT E169294 T1 ATE169294 T1 AT E169294T1 AT 90313923 T AT90313923 T AT 90313923T AT 90313923 T AT90313923 T AT 90313923T AT E169294 T1 ATE169294 T1 AT E169294T1
Authority
AT
Austria
Prior art keywords
benzyl
compounds
treatment
rhodanine derivatives
substituted rhodanine
Prior art date
Application number
AT90313923T
Other languages
English (en)
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Michael Leroy Phillips
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE169294T1 publication Critical patent/ATE169294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90313923T 1989-12-21 1990-12-19 Verbindungen zur behandlung von bauchentzündungen ATE169294T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
ATE169294T1 true ATE169294T1 (de) 1998-08-15

Family

ID=23803709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90313923T ATE169294T1 (de) 1989-12-21 1990-12-19 Verbindungen zur behandlung von bauchentzündungen

Country Status (22)

Country Link
EP (1) EP0434394B1 (de)
JP (1) JP3036853B2 (de)
KR (1) KR0176243B1 (de)
CN (1) CN1029846C (de)
AT (1) ATE169294T1 (de)
AU (1) AU639734B2 (de)
CA (1) CA2032330C (de)
CY (1) CY2100B1 (de)
DE (1) DE69032537T2 (de)
DK (1) DK0434394T3 (de)
ES (1) ES2121748T3 (de)
FI (2) FI104251B1 (de)
HU (1) HU216732B (de)
IE (1) IE904633A1 (de)
IL (3) IL96654A (de)
MX (1) MX23803A (de)
NO (1) NO300458B1 (de)
NZ (1) NZ236472A (de)
PT (1) PT96198B (de)
RU (2) RU2036915C1 (de)
YU (1) YU240690A (de)
ZA (1) ZA9010041B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
ATE135697T1 (de) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivate
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
ATE193284T1 (de) * 1995-09-07 2000-06-15 Lilly Co Eli Verfahren zur herstellung von benzylsubstituierten rhodaninederivaten
PE23298A1 (es) * 1995-09-07 1998-05-05 Lilly Co Eli Forma cristalina alternativa de tazofelona
EP0779282A1 (de) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinon-Verbindungen zur Behandlung von Multiple-Sklerose
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US5773455A (en) * 1996-06-28 1998-06-30 Biomeasure, Incorporated Inhibitors of prenyl transferases
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
US6005142A (en) * 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
US6673816B1 (en) 1998-09-30 2004-01-06 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
JP4977319B2 (ja) * 2002-09-30 2012-07-18 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 嚢胞性線維症膜コンダクタンス制御因子蛋白質阻害薬およびその使用方法
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
WO2011128018A1 (en) * 2010-04-15 2011-10-20 Merck Patent Gmbh Process for the preparation of hydroquinones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83152B (pt) * 1985-08-09 1989-03-30 Lilly Co Eli Processo para a preparacao de compostos di-t-butilfenoicos
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
ES2088965T3 (es) * 1989-04-07 1996-10-01 Lilly Co Eli Derivados de rodanina aril-sustituidos.

Also Published As

Publication number Publication date
FI906273A0 (fi) 1990-12-19
FI906273L (fi) 1991-06-22
CN1052668A (zh) 1991-07-03
CN1029846C (zh) 1995-09-27
ES2121748T3 (es) 1998-12-16
FI19991698A7 (fi) 1999-08-10
YU240690A (sh) 1992-12-21
RU2036915C1 (ru) 1995-06-09
NZ236472A (en) 1993-03-26
KR0176243B1 (ko) 1999-03-20
IL96654A (en) 1995-06-29
CA2032330C (en) 2001-05-08
ZA9010041B (en) 1992-08-26
NO300458B1 (no) 1997-06-02
AU6826690A (en) 1991-06-27
NO905478D0 (no) 1990-12-19
RU2050355C1 (ru) 1995-12-20
HU216732B (hu) 1999-08-30
IL108962A0 (en) 1994-06-24
CY2100B1 (en) 2002-04-05
DE69032537D1 (de) 1998-09-10
EP0434394B1 (de) 1998-08-05
IL108962A (en) 1996-12-05
IE904633A1 (en) 1991-07-17
EP0434394A2 (de) 1991-06-26
DE69032537T2 (de) 1999-01-21
MX23803A (es) 1994-02-28
EP0434394A3 (en) 1992-01-08
JPH04279573A (ja) 1992-10-05
CA2032330A1 (en) 1991-06-22
KR910011812A (ko) 1991-08-07
HUT59915A (en) 1992-07-28
DK0434394T3 (da) 1998-12-14
HU908368D0 (en) 1991-07-29
NO905478L (no) 1991-06-24
JP3036853B2 (ja) 2000-04-24
FI104251B (fi) 1999-12-15
FI19991698L (fi) 1999-08-10
AU639734B2 (en) 1993-08-05
FI104251B1 (fi) 1999-12-15
PT96198B (pt) 1998-05-29
PT96198A (pt) 1991-09-30

Similar Documents

Publication Publication Date Title
ATE169294T1 (de) Verbindungen zur behandlung von bauchentzündungen
ATE210653T1 (de) Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen
ATE174027T1 (de) Heterozyklische verbindungen, ihre herstellung und anwendung
DE69429438D1 (de) Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen
DE68925442D1 (de) Verfahren zur Herstellung von Halbleiterbauelementen sowie Leiterrahmen und ein differentiales Ueberlappungsgerät hierfür
DE68914488D1 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
ATE137735T1 (de) Substituierte cyclohexan-derivate, verfahren zu ihrer herstellung und die anwendung der verbindungen zur behandlung von krankheiten
HU902115D0 (en) Process for producing aryl-substituted rhodanide deriatives
ATA62083A (de) Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATA900589A (de) Stereospezifisches verfahren fuer die herstellung von enantiomeren des 3-substituierten furo (3,4-c) pyridins, so erhaltene enantiomere oder mischungen davon sowie diese enthaltene therapeutische mittel
ATE81118T1 (de) Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.
DE3775496D1 (de) Benzhydryloxyaethyl-piperidine-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen, die diese enthalten.
PT70560A (de) 1,3,4-thiadiazol-2-carbonsaure-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende fungizide und nematizide mittel
DE69527802D1 (de) Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten
FI901371A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi
FR2623501B1 (fr) Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
HUT57749A (en) Process for producing pharmaceutical compositions suitable for treating pathological conditions concerning cerebral blood insufficiency and one special active ingredient
ATE196085T1 (de) Verfahren und zusammensetzung zur behandlung von infektionen unter verwendung von optisch reinem (r) - lomefloxacin

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee